PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
CNN3 |
CNN3: Calponin-3 |
46.330 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
FASLG |
FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 |
46.330 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
46.330 |
Evidence |
|
DUSP1 |
DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 |
DAPK1 |
DAPK1, DAPK: Death-associated protein kinase 1 |
46.330 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
46.330 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
46.050 |
Evidence |
|
DAB1 |
DAB1: Disabled homolog 1 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
45.990 |
Evidence |
|
NR1D1 |
NR1D1, EAR1, HREV, THRAL: Orphan nuclear receptor NR1D1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
45.990 |
Evidence |
|
ZBTB7A |
ZBTB7A, FBI1, LRF, ZBTB7: Zinc finger and BTB domain-containing protein 7A |
HDAC4 |
HDAC4, KIAA0288: Histone deacetylase 4 |
45.990 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PLCB3 |
PLCB3: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 |
45.990 |
Evidence |
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
EPHB4 |
EPHB4, HTK, TYRO11: Ephrin type-B receptor 4 precursor |
45.990 |
Evidence |
|
GRIA1 |
GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor |
GRIK2 |
GRIK2, GLUR6: Glutamate receptor, ionotropic kainate 2 precursor |
45.990 |
Evidence |
|
HAPLN1 |
HAPLN1, CRTL1: Hyaluronan and proteoglycan link protein 1 precursor |
TNC |
TNC, HXB: Tenascin precursor |
45.990 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
45.990 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
45.990 |
Evidence |
O
|
NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
45.980 |
Evidence |
|
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
45.980 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
PCBP2 |
PCBP2: Poly(rC)-binding protein 2 |
45.980 |
Evidence |
|
TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
THBS1 |
THBS1, TSP, TSP1: Thrombospondin-1 precursor |
45.980 |
Evidence |
|
MYBL2 |
MYBL2, BMYB: Myb-related protein B |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
45.980 |
Evidence |
|
F2 |
F2: Prothrombin precursor |
CTSL |
CTSL: Cathepsin L precursor |
45.860 |
Evidence |
|
VAMP1 |
VAMP1, SYB1: Vesicle-associated membrane protein 1 |
STX12 |
STX12: Syntaxin-12 |
45.850 |
Evidence |
|
STX12 |
STX12: Syntaxin-12 |
SYBL1 |
SYBL1: Synaptobrevin-like protein 1 |
45.850 |
Evidence |
|
ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
45.800 |
Evidence |
|
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
CBLC |
CBLC, CBL3, RNF57: Signal transduction protein CBL-C |
45.270 |
Evidence |
|